Prot #AC-065B302: SELECT: SELExipag in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Group-Sequential, Adaptive, Phase 3 Study with Open-Label

Project: Research project

Project Details

StatusFinished
Effective start/end date8/12/19 → 11/30/24

Funding

  • Janssen Research & Development, LLC ((OE) Prot #AC-065B302)